Biotech · Private company
UCB Pharma
Track this companyFree. Adds UCB Pharma to your Dealase workspace and tells you when its record changes.
Clinical trials259 recruiting or active
Pipeline programs17From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline17
- Antiepileptic drugs with market authorization available per countryPhase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- BrivaracetamPhase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- Brivaracetam (BRV)Phase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- Brivaracetam 10 mgPhase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- Brivaracetam 2.5 mgPhase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- Brivaracetam 25 mgPhase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- BRV 2.5 mgPhase 3 · Unverricht-Lundborg DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- BRV 25 mgPhase 3 · Unverricht-Lundborg DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- BRV 50 mgPhase 3 · Unverricht-Lundborg DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Certolizumab PegolPhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Certolizumab Pegol + Methotrexate (MTX)Phase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- MethotrexatePhase 3 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- CDP 6038 SCPhase 2 · ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- CDP6038Phase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- CDP6038Phase 2 · ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- Seletracetam (UCB44212)Phase 2 · Epilepsy, PartialClinicalTrials.gov · fetched Nov 12, 2026
- Tocilizumab (Actemra or RoActemra)Phase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Efficacy of Bimekizumab in Adults With Pyoderma GangrenosumPHASE2 · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT07767864 · fetched Nov 12, 2026
- EEG Dynamics in Lennox-Gastaut Syndrome Patients Undergoing Fenfluramine TreatmentENROLLING_BY_INVITATION · started May 1, 2026ClinicalTrials.gov NCT07555171 · fetched Nov 12, 2026
- Epilepsy Emergency Department High Utilizer ProgramENROLLING_BY_INVITATION · started May 1, 2026ClinicalTrials.gov NCT07663240 · fetched Nov 12, 2026
- Clinical Utility of Reduced EEG Home Monitoring in Fenfluramine Titration for Dravet and LGSNA · ENROLLING_BY_INVITATION · started Apr 20, 2026ClinicalTrials.gov NCT07225231 · fetched Nov 12, 2026
- Zilucoplan for Severe gMG ExacerbationsPHASE3 · RECRUITING · started Jan 20, 2026ClinicalTrials.gov NCT07215949 · fetched Nov 12, 2026
- Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated AssessmentRECRUITING · started Feb 26, 2025ClinicalTrials.gov NCT06866483 · fetched Nov 12, 2026
- Bimekizumab in Plaque PsoriasisPHASE4 · COMPLETED · started Jun 3, 2024ClinicalTrials.gov NCT06336343 · fetched Nov 12, 2026
- Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-AssessmentCOMPLETED · started Mar 28, 2024ClinicalTrials.gov NCT06381284 · fetched Nov 12, 2026
- Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen RepositoryRECRUITING · started Aug 1, 2020ClinicalTrials.gov NCT04115566 · fetched Nov 12, 2026
- Novel Quantitative MRI for Axial SpondyloarthritisTERMINATED · started Jan 15, 2020ClinicalTrials.gov NCT03778515 · fetched Nov 12, 2026
- IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIAPHASE4 · COMPLETED · started Aug 1, 2015ClinicalTrials.gov NCT02451748 · fetched Nov 12, 2026
- OTIS Cimzia Pregnancy RegistryACTIVE_NOT_RECRUITING · started Mar 1, 2012ClinicalTrials.gov NCT01797224 · fetched Nov 12, 2026
- A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid ArthritisPHASE3 · COMPLETED · started Jan 1, 2012ClinicalTrials.gov NCT01519791 · fetched Nov 12, 2026
- A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid ArthritisPHASE3 · COMPLETED · started Jan 1, 2012ClinicalTrials.gov NCT01521923 · fetched Nov 12, 2026
- Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With EpilepsyPHASE3 · COMPLETED · started Aug 1, 2011ClinicalTrials.gov NCT01364597 · fetched Nov 12, 2026
- Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset SeizuresPHASE3 · COMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01261325 · fetched Nov 12, 2026
- Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) TherapyPHASE2 · COMPLETED · started Nov 1, 2010ClinicalTrials.gov NCT01242488 · fetched Nov 12, 2026
- To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using MethotrexatePHASE1_PHASE2 · COMPLETED · started Oct 1, 2009ClinicalTrials.gov NCT01009242 · fetched Nov 12, 2026
- Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary NailingPHASE2 · COMPLETED · started Sep 2, 2009ClinicalTrials.gov NCT00907296 · fetched Nov 12, 2026
- Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset SeizuresPHASE3 · COMPLETED · started Sep 1, 2007ClinicalTrials.gov NCT00464269 · fetched Nov 12, 2026
- Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and AdultsPHASE3 · COMPLETED · started Nov 1, 2006ClinicalTrials.gov NCT00368251 · fetched Nov 12, 2026
- Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison StudyPHASE4 · COMPLETED · started Oct 1, 2006ClinicalTrials.gov NCT00590122 · fetched Nov 12, 2026
- This Trial, Evaluating the Long-term Safety and Tolerability of Brivaracetam Will Provide Subjects Suffering From Epilepsy, Who May Have Benefited From Brivaracetam as Adjunctive Treatment, the Opportunity to Receive Open Label Brivaracetam TreatmentPHASE3 · COMPLETED · started Jan 1, 2006ClinicalTrials.gov NCT00150800 · fetched Nov 12, 2026
- Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking LevetiracetamPHASE2 · COMPLETED · started Aug 31, 2005ClinicalTrials.gov NCT00152503 · fetched Nov 12, 2026
- Brigham and Women's Rheumatoid Arthritis Sequential StudyACTIVE_NOT_RECRUITING · started Mar 1, 2003ClinicalTrials.gov NCT01793103 · fetched Nov 12, 2026